wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37604501-8C475D9F-3C5A-4AA8-BBCC-6CB6FA9D1E10
Q37604501-8C475D9F-3C5A-4AA8-BBCC-6CB6FA9D1E10
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-8C475D9F-3C5A-4AA8-BBCC-6CB6FA9D1E10
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P2860
Q37604501-8C475D9F-3C5A-4AA8-BBCC-6CB6FA9D1E10
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-8C475D9F-3C5A-4AA8-BBCC-6CB6FA9D1E10
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f30388c170bc2d9f5f8d6741cba5d47e45c86182
P2860
Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study